iShares Biotechnology ETF (IBB) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Asset Management industria. La empresa tiene su sede en San Francisco, DE, United States.
IBB tiene fecha de IPO 2001-02-12, cotiza en el NASDAQ Global Market, una capitalización de mercado de $8.48B.
The iShares Biotechnology ETF is a non-diversified fund that allocates at least 80% of its assets to biotechnology companies and securities that mirror its underlying index. The fund may invest up to 20% of its assets in derivatives including futures, options, and swap contracts, along with cash and cash equivalents, to achieve its investment objectives. As a passively managed exchange-traded fund, it provides investors with broad exposure to the biotechnology sector through a single, liquid investment vehicle.
